The development of combinational mastitis treatments is anticipated to open up the new avenue for Bovine Mastitis Market

Market Overview:
Bovine mastitis is an inflammation of the mammary gland in dairy cattle caused due to bacterial infection. It leads to physical, chemical and usually persistent pathological changes in the mammary gland and milk. Staphylococcus aureus and Streptococcus species are the main pathogens causing bovine mastitis. Treatment involves use of antibiotics for treating infection and anti-inflammatory drugs to reduce pain and swelling. Vaccines are also available in market to prevent mastitis. Early detection and treatment is important for reducing economic losses to dairy farmers.

Market Dynamics:
Growing dairy industry is a key driver for bovine mastitis market. Rising demand for dairy products globally is resulting in increasing number of dairy cattle and farms. This increases risk of mastitis requiring prevention and treatment products. Technological advancements leading to development of rapid diagnostic tests and combination therapy is another factor fueling market growth. Rapid test aids in early diagnosis while combination therapy helps fight infection better. However, growing antibiotic resistance in mastitis causing pathogens poses a challenge for market. Farmers and regulatory bodies are concerned about residue of antibiotics in milk consumed by humans. This is pushing development of alternative therapies like bacteriophages and herbal extracts.
Segment Analysis
The bovine mastitis market is dominated by the therapeutic segment, which accounts for over 65% market share. Within therapeutics, antibiotics sub-segment dominates owing to high adoption for effective treatment of clinical and sub-clinical mastitis. Antibiotics aid in curing bacterial infection and reducing inflammation, making it the preferred choice for mastitis treatment.

PEST Analysis
Political: Governments across regions are focusing on dairy farmers' welfare through subsidies and educational programs to boost farmers' income and curb dairy cattle health issues like mastitis.
Economic: Increasing awareness about milk quality and economic losses due to mastitis is compelling farmers and dairy cooperative societies to invest significantly in advanced mastitis detection kits and treatment solutions.
Social: Rising consumer preference for antibiotic residue free and organic dairy products is prompting dairy farmers and cooperatives to extensively control and treat mastitis for animal welfare and production of high quality milk.
Technological: Continuous innovations in mastitis diagnosis technologies like Rapid Mastitis Tests and advanced calibrations in milking cluster are helping detect sub-clinical mastitis on-time for quick therapeutic intervention.

Key Takeaways
The global Bovine Mastitis Market is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period, due to increasing dairy production and rising cattle health concerns. North America dominates the market owing to robust dairy infrastructure, high dairy farming adoption, and progressive dairy herd health management practices. Key regional markets include Europe and Asia Pacific. Key players operating in the bovine mastitis market are Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd. Key players are focused on expanding their mastitis product portfolios for clinical as well as sub-clinical mastitis treatment and developing new diagnostics and vaccines.

The bovine mastitis market in the North American region dominates with over 30% value share owing to robust veterinary infrastructures and rising awareness among dairy farmers regarding dairy cattle health and milk quality. The U.S. represents the largest economy in this region, characterized by advanced farm management and herd health practices.

Key players operating in the bovine mastitis market are focusing on expanding their mastitis product portfolios for clinical as well as sub-clinical mastitis treatment. Companies are involved in extensive research and development to develop new generation mastitis diagnostics, vaccines, teat dips, and other therapeutics with advanced formulations and new modes of action for effective mastitis control.

Read More: https://www.rapidwebwire.com/bovine-mastitis-market-trends/